Compounds and their use for specific and simultaneous inhibition of genes involved in diseases and related drugs

Details for Australian Patent Application No. 2010202859 (hide)

Owner Centre National de la Recherche Scientifique (C.N.R.S.) Institut National de la Sante et de la Recherche Medicale (INSERM) Museum National D'Histoire Naturelle

Inventors Arimondo, Paola Barbara; Boutorine, Alexandre; Sun, Jian-Sheng; Bailly, Christian; Helene, Claude; Garestier, Therese

Agent Watermark

Pub. Number AU-A-2010202859

Parent 2004221687

Filing date 7 July 2010

Wipo publication date 29 July 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 35/00 (2006.01) Antineoplastic agents

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 July 2010 Complete Application Filed

29 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202859

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202860-Method and system for autonomous channel coordination for a wireless distribution system

2010202858-Split Bubble Float